The kinetic properties of transport system T, which is specific for uptake of aromatic amino acids, were studied in rat erythrocytes in the presence of leucine in order to block the neutral amino acid transport system L. Since the triiodothyronine (T3) transport system and system T are closely related, the trans effect of T3 and tryptophan on [3H]tryptophan transport and the trans effects of aromatic amino acids on [125I]T3 transport were studied. Equilibriumexchange, zero-trans and infinite-trans studies of [3Hltryptophan transport indicated that system T in rat erythrocytes is a simple carrier with exchanging properties resulting in trans-acceleration of influx and trans-inhibition of efflux when tryptophan was present at the trans side of the membrane. In erythrocytes preloaded with unlabelled tryptophan, countertransport resulted in a 7-fold accumulation of labelled substrate inside the cells. T3 on the trans side of the membrane inhibited both influx and efflux of tryptophan, with K1 values similar to the Km values of the T3 transport system. Extracellular tryptophan trans-inhibited ['25I]T3 efflux in a manner similar to [3H]tryptophan efflux. Preloading erythrocytes with tryptophan resulted in trans-acceleration of T3 uptake and a transient 5-fold accumulation of free T3 into erythrocytes. Phenylalanine and tyrosine (but not the D-isomer of tryptophan or non-aromatic amino acids) also produced trans-acceleration for T3 uptake and T3 countertransport. These results are compatible with a kinetic model assuming a common simple carrier of T3 and tryptophan transport and point to a countertransport pathway driving the uphill uptake of T3 by hetero-exchange with intracellular aromatic amino acids.
INTRODUCTION
Thyroxine is deiodinated in peripheral tissues to active triiodothyronine (T3) which binds to chromatin-associated receptors and subsequently regulates the expression of specific genes in target cells [1] . Thyroid hormones have first to cross the plasma membrane to reach their intracellular targets, and there is increasing evidence that this is performed by specialized, saturable and stereospecific transport systems [2] [3] [4] [5] [6] .
Several studies in vivo point to the key role of these transport systems in thyroid hormone action, and suggest that active energy-dependent processes are involved in the cellular uptake of thyroid hormones [7] [8] [9] [10] . Also, a number of studies in vitro on isolated tissues or cells suggest Na+-and ATP-dependent thyroid hormone transport across the plasma membrane [11] [12] [13] [14] . Most of the studies have dealt with the inhibitory effect of metabolic blockers (such as KCN, oligomycin or antimycin) on thyroid hormone uptake by target cells [2] [3] [4] [5] 12, 15] .
However, other studies indicate that carrier-mediated T3 uptake appears to be Na+-independent in several cell types [6, [16] [17] [18] [19] . Also, various drugs, usually used as metabolic blockers, were either without effect or inhibited the T3 transport systems independently of ATP depletion [6, 17, 19, 20] . These observations are compatible with facilitated rather than active transport, suggesting that mechanisms other than direct coupling to ionic gradients and ATP hydrolysis may be involved in active thyroid hormone uptake.
One way the cell can maintain a gradient of a transported substance is by hetero-exchange with intracellular substrates sharing the same carrier. Thus the Na+-independent amino acid transport system L (which has strongly exchanging properties) can drive the uphill transport of neutral amino acids [21] . As thyroid hormones are iodoamino acids, they may be taken up by such a mechanism, which would imply sharing transport systems with other amino acids.
There is evidence that thyroxine is not transported in Ehrlich cells by neutral amino acid carriers [22] and that the T3 uptake mechanism in hepatoma cells is distinct from the amino acid transport system A [16] . However, in embryonic-chick cartilage and isolated rat thymocytes, thyroid hormones appear to enhance amino acid uptake preferentially via the Na+-independent system L rather than via the Na+-dependent system A (reviewed in [23] ). On the other hand, recent reports indicate that phenylalanine and other L-system amino acids inhibit the internalization of thyroid hormones in neuroblastoma cells [24] . We previously showed [25] that the T3 transport system of rat erythrocytes was related to amino acid transport system T, previously characterized in human erythrocytes [26, 27] as a Na+-independent system, specific for aromatic amino acids. T3and tryptophan are taken up into erythrocytes by interacting pathways whose activities are linked in the erythrocytes of several species [25] . In particular, both activities are considerably higher (100-500 times) in rat erythrocytes than in human erythrocytes.
None of these studies considered countertransport, i.e. stimulation of thyroid hormone uptake by intracellular amino acids. The present work was therefore undertaken to study the detailed kinetic properties of system T in rat erythrocytes (previously used as a cellular model to characterize the kinetics of T3 transport [18, 25, 28] ) and its exchanging properties, particularly in relation to T3 countertransport. 
Preparation of washed erythrocytes
Blood from male Wistar rats (250 g; Iffa Credo, France) was collected into heparin, and erythrocytes were sedimented and washed as previously described [18, 28] and suspended in buffer A (125 mM-NaCl, 20 mM-KCl, 4 mM-MgCI2, 10 mM-glucose, 4.05 mM-Na2HPO4, 0.95 mM-NaH2PO4, pH 7.4 [25] .
The equilibrium concentrations of labelled and unlabelled tryptophan and unlabelled T3 were determined as previously described [28] . Free T3 concentrations were corrected for instantaneous adsorption at the cell surface [25] .
RESULTS AND DISCUSSION
Kinetics of tryptophan transport by system T in rat erythrocytes System T in rat erythrocytes was characterized by using the formalism developed by Lieb & Stein [29, 30] , in the presence of 20 mM-leucine to exclude tryptophan transport via system L [25, 27] . The outside of the erythrocytes was arbitrarily designated side 1 and the cytoplasmic side as side 2. Maximal velocities (V) and apparent Michaelis-Menten constants (K) were determined in the three transport modes: zero-trans influx (zt, 1 2), zero-trans efflux (zt,2 1) and equilibrium-exchange (ee). Zero-trans influx and efflux of tryptophan through system T were saturable and obeyed simple Michaelis-Menten kinetics (Fig. 1) . The mean K values for influx (Kzl ) and efflux (Kzt ) obtained from three independent experiments were 0.47 and 0.99 mm respectively ( Table 1 ). The V was lower for influx than for efflux. The asymmetry parameter calculated from the K ratio (A = Kzl /KzI ) was 0.47, similar to the value of 0.46 calculated from the V ratio (A = Vzl / Vzt ). Hence the apparent affinity is -2-fold higher outside than inside the cells, whereas the reverse holds for maximal velocities of transport. This asymmetry of the tryptophan transport system is opposite to that of the related T3 carrier, whose affinity for T3 is -6.5 times higher inside than outside the erythrocyte [28] .
Substrate concentrations were equal on both sides of the membrane in equilibrium-exchange experiments. Under this condition, K and V (Kee and ree) were -1.3 times the respective values for zero-trans influx and 1.5-1.6-fold lower than the respective values for zero-trans efflux ( Table 1) .
The resistance parameters R12, R21 and Ree are the reciprocals of the maximum velocities Vzl, Vzl and Vee, and are functions of the rate constants for conformational changes of the simple carrier [30] in one of the three modes: (1) loaded in the 1-to-2 (outside to inside) direction and empty in the 2-to-1 direction (zero-trans influx); (2) loaded in the 2-to-1 direction and empty in the l-to-2 direction (zero-trans efflux); and (3) loaded in both directions (equilibrium-exchange). ROO, which is equal to R12+ R21-Ree [30] , is the resistance parameter when the carrier is empty in both directions. As shown in Table 1 [29, 30] . The simple carrier model assumes two interconvertible conformations of the unloaded carrier, each of which interacts with substrate at one surface of the membrane [30, 31] . Initial velocities (v) The three estimates of KOO, the simple carrier affinity parameter, were similar (Table 1) , with a mean value of 0.63 + 0.03 mM. This also indicates that the simple carrier model holds [31] for tryptophan transport in rat erythrocytes.
The ratio Roo/Ree is approx. 1 ( Table 1 ), so that the mobility (in both directions) of the empty carrier is equal to that of the loaded carrier. However, the fact that equilibrium-exchange V is lower than zero-trans efflux V, but higher than zero-trans influx V, suggests that the empty carrier has a higher mobility than the substrate-loaded carrier in the 1-to-2 direction, whereas the reverse would hold for the 2-to-I direction.
Finally, the first-order rate constants for exchange (nee= Vee/Kee) and for the two zero-trans fluxes (Hlzl = Vzl /Kzl and rIzl = Vzl /Kz) are similar (Table 1) , as expected for a simple carrier [31] . This demonstrates the internal consistency of the data and the methods used to determine the kinetic parameters.
Effects of extracellular tryptophan or T3 on tryptophan efflux Fig. 2 shows the time course of labelled tryptophan efflux from preloaded erythrocytes. A saturating concentration (5 mM) of unlabelled tryptophan in the efflux medium slowed the initial phase of efflux. A new equilibrium level was reached which was identical with the control level with no unlabelled tryptophan (Fig. 2a) . Indeed, the higher rate of inside re-orientation of empty carrier than of loaded carrier, predicted from the kinetic data (Table 1) , results in trans-inhibition of efflux by extracellular substrate.
In the experiment shown in Fig. 2(b) , the initial velocities of efflux (0-5 s) were obtained by linear regression, as described in the Experimental section. The slope determined in the presence of 5 mm unlabelled tryptophan (3.80+0.15 min-') was significantly lower (P < 0.01; F test) than that measured in the absence of tryptophan (5.43 + 0.09 min-').
[3H]Tryptophan efflux was trans-inhibited 1.5-fold (mean of two independent determinations; range 1.4-1.6). This value is close to the ratio of the measured V for zero-trans efflux and equilibrium-exchange, as expected for the carrier model [32] , since Vzl/ Vee 1.6. Transinhibition of system-T-mediated tryptophan efflux also occurs in human erythrocytes [27] .
The effect of extracellular T3 on tryptophan efflux was also investigated (Figs. 2a and 2b) : efflux was completely transinhibited by 10 guM-T3. This is similar to the previously reported effect of T3 on its own transport system, for which transinhibition occurs in both the inward and outward directions [28] . This observation validates the use of 10/LM unlabelled T3 as a stop solution for blocking both influx [25] and efflux (the present work) of labelled tryptophan and as a wash solution for preventing the loss of internalized tryptophan.
This inhibition was studied at various concentrations of extracellular unlabelled T3 by using Dixon plots of the data (Fig.   3a) . Since the concentration of [3H]tryptophan was 4 Kz%, the trans-inhibition constant (trans-K) of outside T3 was obtained from the abscissa intercept of the plot. The mean value of the constant from three independent experiments was 0.14 + 0.03 ,CM.
This trans-K, value is similar to the K of T3 uptake (0.13 ,UM) and to the trans-K, of T3 efflux (0.12 /SM) reported previously [28] , suggesting that trans-inhibition of tryptophan efflux by T3 is mediated by the T3 transport system.
Trans-inhibition of T3 efflux by extraceliular tryptophan
The efflux of labelled T3 from preloaded erythrocytes was slower when the efflux medium contained 5 mm unlabelled tryptophan (Fig. 4) . The (Fig. 5a ) and found to be half-maximal within approx. 3 min. Therefore, in the countertransport experiment, intracellularly accumulated [3H]-tryptophan returned to the control level as a consequence of the time-dependent loss of preloaded unlabelled tryptophan. This trans-acceleration of influx is in agreement with a higher rate of external translocation of loaded carrier than of empty carrier, in accord with the kinetic data (R12 being higher than Ree) ( Table 1) .
Trans-acceleration of [3H]tryptophan influx was studied under initial-velocity conditions in the presence of preloaded tryptophan (10 mM). Initial velocities were calculated from the slopes obtained by linear regression (cell-associated radioactivity versus time), as described in the Experimental section. The ratio of the slopes, relative to control, was 1.5+0.1 (mean of three independent experiments), close to the ratio of the experimental V values for zero-trans influx and equilibrium exchange (Table 1) , since Vee/Vzl = 1.3. Again, this correlates well with the carrier model [32] .
The kinetic parameters K and V can be determined under infinite-trans conditions (Kit and Vit) (i.e. in the presence of a saturating concentration of unlabelled substrate on the trans side of the membrane) provided that Roo * 0 [31] . A Hanes plot of uptake data obtained in the presence of a saturating intracellular concentration of tryptophan (infinite-trans influx) is shown in Fig. 1 (Table  1) indicates that V, rather than K, is affected by substrate on the trans side of the menmbrane. These experiments provided an additional independent estimate of the simple carrier affinity parameter, KOO = K'2 (Ree/R2i) [31] . The resulting value was 0.67 mm, compatible with the mean KOO value in Table 1 and therefore with the simple carrier model.
Finally, a high concentration of T3 inside the cells (3.5 ,UM free T3) completely inhibits tryptophan uptake (Fig. 5a) . The transinhibition of labelled tryptophan influx was studied with erythrocytes preloaded with increasing concentrations of unlabelled T3 (Fig. 3b) . The mean inside trans-inhibition constant from three independent experiments was 26 + 5 nm. This K1 value is similar to the K of T3 efflux (18 nM) and to the trans-K, of T3 influx (21 nM) reported previously [28] . This again strongly suggests that interaction of T3with tryptophan transport is mediated by the previously characterized T3 carrier. Countertransport of aromatic amino acids and T3
The uptake of [125IT3 was accelerated when erythrocytes were preloaded with unlabelled tryptophan (10 mM), and the hormone accumulated above the equilibrium level obtained in the absence of tryptophan (Fig. 5b) . The overshoot was similar to that observed for [3H]tryptophan uptake (2.9 + 0.2 times the control, n = 5). As previously reported [18] , based on the intracellular water content of erythrocytes, T3 is accumulated about 70-fold over the medium concentration at equilibrium in the unloaded control condition. This was attributed to intracellular binding of T3 [18] Trans-inhibition, rather than trans-acceleration and overshoot, occurred when cells were preloaded with D-tryptophan instead of L-tryptophan (Fig. 5b) . D-Tryptophan, although it is a competitor of L-tryptophan uptake [25, 27] , is said not to be transported by system T [27] . This indicates that efflux via system T is required for acceleration and subsequent overshoot, and not just binding to it. Preloading with 10 mM-serine, a substrate of the ASC amino acid-transport system, had no effect on the time course of T3 uptake.
Preloading with phenylalanine, another substrate of system T, resulted in a stronger trans-acceleration of [126I]T3 initial uptake (Fig. Sb) , suggesting that the outward movement of the phenylalanine-carrier complex is faster than that of the tryptophan-carrier complex. However, the overshoot was more transient and reached a lower level than with preloading (after a 25 s uptake, the concentration gradient of free T3 was -1.5; mean of two experiments), possibly owing to the phenylalanine efflux being more rapid than the tryptophan efflux. Tyrosine produced a T3 concentration gradient of 2.5 (one experiment).
Trans-acceleration of [125I]T3 influx was studied under initialvelocity conditions in the presence of various preloaded amino acids (10 mM), particularly those which are substrates of system T: tryptophan, phenylalanine and tyrosine. Initial velocities were calculated from the slopes obtained by linear regression (cellassociated radioactivity versus time), as described in the Experimental section. The ratio of the slopes relative to control was 1.3+0.1 (n = 4) for L-tryptophan, 2.1+0.1 (n = 4) for phenylalanine, 1.2 (n = 2; range 1.1-1.3) for tyrosine and 0.55 + 0.06 (n = 3) for D-tryptophan. This last value, lower than 1, confirms that D-tryptophan trans-inhibits, rather than transaccelerates, tryptophan uptake. Glycine, serine, glutamine, lysine, glutamic acid and taurine (10 mM) caused neither transacceleration nor trans-inhibition (ratio of the slopes = 1). These amino acids are respectively the main substrates of the amino acid-transport systems Gly, ASC, N, Ly+, Glu and ,f, present in human erythrocytes [33] . Thus binding to, or transport by, these carriers is not involved in trans-acceleration by aromatic amino acids. System L is also not involved, since 20 mM-leucine was present both intra-and extra-cellularly throughout the experiments.
Possible significance of T3/tryptophan interactions at the transport site These kinetic data for tryptophan transport by the rat erythrocyte system T are fully compatible with a simple carrier model, as defined by Stein [30, 31] , and system T can drive the uptake of substrates against their concentration gradients. The rat erythrocyte system T exhibits unusual asymmetric exchange properties, resulting in trans-inhibition of tryptophan exit and transstimulation of tryptophan uptake, a behaviour also reported for system T in human erythrocytes [27] . Similar trans effects of tryptophan on the T3 carrier (which was previously shown to exhibit pore-like kinetic properties [28] ) are also observed. Since, in addition, the T3 trans-inhibition of tryptophan transport is mediated by the T3 carrier, there is no reason to assume any kinetic model more complicated than a common simple carrier for T3 and tryptophan. T3 trans-inhibition of T3 and tryptophan transport would then result from either slow translocation (transconformation) of the T3-carrier complex (compared with that of the unloaded carrier) or slow dissociation of this complex at the membrane surfaces. Whether this kinetic model reflects the activity of a common carrier for both substrates or that of a set of interactive transport systems needs purification of the protein(s) implicated in the transport of T3 and tryptophan and reconstitution of transport activities.
The system-T-mediated trans-acceleration of T3 uptake by intracellular aromatic amino acids induces active T3 transport, resulting in the intracellular free T3 concentration being higher than the extracellular concentration. The physiological significance of this mechanism, by which T3 is pumped up its concentration gradient in rat erythrocytes, requires further study. It is not known if rat erythrocytes can accumulate sufficiently high intracellular levels of aromatic amino acids to maintain a sustained counterflow of T3. This would implicate other amino acid-exchanging systems (such as system L) and/or Na+-dependent amino acid-transport systems (such as system ASC). Both types of carrier are present in human erythrocytes [33] , but rat erythrocytes are said to lack Na+-dependent carriers [34] .
Countertransport, as an indirect mechanism for coupling T3 uptake to the ionic gradients and, ultimately, to cellular energy, would be of great importance in target cells, since the hormone gradient across the plasma membrane might modulate T3 binding to nuclear receptors. There are reports of system T-like transport activities in rat hepatocytes [35] and mouse blastocytes [36] , but no indication as to whether they are linked to thyroidhormone uptake. The existence of such a countertransport pathway, or a similar one, in target cells might explain some of the discrepancies in the roles of Na+ and cellular ATP in thyroidhormone uptake (see the Introduction). Such observations would depend on whether the cellular system used in vitro had kept all the components (particularly the gradient concentration of intracellular amino acids involved in countertransport) required to couple the T3 flow to the Na+ gradient and ATP hydrolysis. Erythrocytes provide a model system for studying the active mechanisms of T3 uptake, and the implied hetero-exchange with intracellular amino acids.
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